{
    "organizations": [],
    "uuid": "cdb246ea634676e85c73dad0abbe3a86ff75d5a5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-casi-pharma-says-advisory-committe/brief-casi-pharma-says-advisory-committee-to-review-evomela-between-april-25-26-idUSASC09V0Z",
    "ord_in_thread": 0,
    "title": "BRIEF-CASI Pharma Says Advisory Committee to Review Evomela Between April 25-26",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 5 (Reuters) - CASI Pharmaceuticals Inc:\n* CASI PHARMACEUTICALS PROVIDES UPDATE ON EVOMELAÂ® * CASI PHARMACEUTICALS - RECEIPT OF LETTER FROM CENTER FOR DRUG EVALUATION FOR INJECTION SCHEDULED FOR REVIEW BY ADVISORY COMMITTEE\n* CASI PHARMACEUTICALS INC - ADVISORY COMMITTEE MEETING SCHEDULED TO TAKE PLACE BETWEEN APRIL 25-26, 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-05T20:18:00.000+03:00",
    "crawled": "2018-04-06T21:46:55.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "casi",
        "pharmaceutical",
        "inc",
        "casi",
        "pharmaceutical",
        "provides",
        "update",
        "casi",
        "pharmaceutical",
        "receipt",
        "letter",
        "center",
        "drug",
        "evaluation",
        "injection",
        "scheduled",
        "review",
        "advisory",
        "committee",
        "casi",
        "pharmaceutical",
        "inc",
        "advisory",
        "committee",
        "meeting",
        "scheduled",
        "take",
        "place",
        "april",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}